Hillhouse Capital Management
Lower valuations, less leverage could drive China PE returns - HKMA Forum
China private equity could deliver some strong vintages relative to other markets given falling valuations, a deepening pool of management talent, and a historical emphasis on driving returns through growth rather than leverage, industry participants...
PE-backed J&T Express raises $499m in Hong Kong IPO
J&T Global Express, an express delivery business that launched in Indonesia and expanded region-wide, traded flat on debut following a HKD 3.9bn (USD 499m) Hong Kong IPO.
China carpooling player Dida revives Hong Kong IPO bid
Dida, a PE-backed Chinese car-pooling and ride-hailing platform, has filed to list in Hong Kong – for the fourth time in three years. There are records of lapsed registrations from 2020, 2021, and earlier in 2023.
Hillhouse buys offshore corporate services unit from Harneys
Hillhouse Investment, the buyout and growth capital unit of Asia-based Hillhouse Group, has agreed to acquire the fiduciary services business of global offshore law firm Harneys.
VC investors primed for exit with China Youzan reorganisation
Hillhouse Capital and Matrix Partners China are set for liquidity events after China Youzan, an e-commerce software-as-a-service (SaaS) business listed in Hong Kong, agreed to take full control of its key subsidiary for HKD 2.6bn (USD 334.5m).
Bosch backs China’s AutoCore.ai
Bosch Ventures and Boyuan Capital - both investment units of Germany-headquartered engineering and technology giant Bosch Group - have joined a Series A extension for Chinese automotive systems software supplier AutoCore.ai.
Logistics start-up Lalatech pursues Hong Kong IPO
Lalatech Holdings, the parent company of Hong Kong delivery platform Lalamove, has filed for an IPO in Hong Kong. This would represent a liquidity event for the likes of Hillhouse Capital, MindWorks Ventures, and Shunwei Capital.
China's Structure Therapeutics soars on US debut
Structure Therapeutics, a China and US-based drug developer specialising in novel oral therapeutics, performed strongly on its trading debut following an upsized USD 161.1m NASDAQ IPO.
Hillhouse-backed China pet services business seeks US listing
New Ruipeng Pet Group, a China-based pet care services platform that counts Hillhouse Capital as a significant shareholder, has filed for an IPO in the US.
China cell therapy developer raises $75m
Iaso Biotherapeutics, a Chinese cell therapy developer focusing on oncology treatments, has raised nearly CNY 500m (USD 75m) in an extended Series C round.
Capcon Semiconductor raises $50m
Hillhouse Capital, Cowin Capital, Chengchuang Capital, and SAIC Motor Corporation's Shangqi Capital have participated in a USD 50m extended Series B round for Capcon, a Chinese-founded supplier of semiconductor assembly and packaging equipment.
Cloudview leads $221m round for China solar panel maker
China’s Cloudview Capital has led a CNY 1.5bn (USD 221m) Series B round for Astronergy, a solar panel manufacturer based in Zhejiang province.
Hillhouse buys Australia CRO George Clinical
Hillhouse Capital has agreed to buy George Clinical, an Australia-based clinical research organisation (CRO) with a global footprint, for an undisclosed sum.
Chinese investors sell international assets of condom maker LifeStyles
A Chinese investor group featuring several private equity firms has sold the non-China assets of LifeStyles Healthcare, a global sexual health and wellness platform best known for the Lifestyles condom brand, to US-based Linden Capital Partners.
China's Giant Biogene trades up after $70m Hong Kong IPO
Giant Biogene, a China-based producer of skin treatments that use bioactive ingredients, gained nearly 10% on debut following a HKD 549.4m (USD 70m) Hong Kong IPO.
Hillhouse launches China incubation unit
Hillhouse Capital has introduced an incubation strategy that is intended to support China-based start-ups from incubation through the seed stage.
Prosperity7 backs China-founded unstructured data specialist Zilliz
Prosperity7 Ventures, a venture capital fund established by Saudi Arabia state oil giant Saudi Aramco, has led a USD 60m Series B extension for China-founded open-source software developer Zilliz.
Hillhouse reaches first close on China carbon neutrality fund
Hillhouse Capital has reached the first close on its debut renminbi-denominated carbon neutrality fund, which has an overall target of around CNY 4bn (USD 597m).
China's JD Property closes $800m Series B
Warburg Pincus and Hillhouse Investment have re-upped in JD Property, the infrastructure property asset management arm of Chinese e-commerce giant JD.com, as part of a USD 800m Series B round.
PE-owned Belle Fashion files for Hong Kong IPO
China’s largest women’s footwear retailer Belle Fashion, which is backed by Hillhouse Capital and CDH Investments, has filed for a Hong Kong IPO with a reported target of USD 1bn.
China VC: Funding puzzles
Late-stage investors are appearing in earlier funding rounds in China, offering premium valuations but potentially leaving start-ups in situations where they have too much too soon
Deal focus: Sobot’s journey from underdog to top dog
A USD 100m Series D confirmed Sobot’s status as a stalwart of China’s customer service software space, but getting there has not been a straightforward process
AVCJ Awards 2021: Deal of the Year – Large Cap: China Biologic
For Centurium Capital, China Biologic was no ordinary take-private. It was the culmination of a multi-year effort to tighten the company’s shareholding structure and root out management inefficiencies